-
oral thienopyridine that irrereversibly inhibits ADP
does not inhbit cAMP
clopidigrel - plavix
-
oral agent that irrereversible inhibits ADP binding to platelet receptor
for acute coronary syndrome
prodrug that bypasses CYP2C19 metabolism
potential thrombotic thrombocytopenia prupura
prasugrel - effient
-
anti-platelet indicated for unstable angina and non-Q wave MI
integrin receptor glycoprotein IIIb/IIa receptor blocker
IV only with a longer half life
contains sulpha
tirofiban - aggrastat
-
anti-platelet not to be administered in same line as furosemide because of its basic content
peptide based drug - shorter half life
IV only
eptifibatide-integrillin
-
reversible anti-platelet for acute MI
acts by monoclonal antibody blocker of integrin receptor
administer IV stand alone line - no floaters
most common side effect is bleeding
abciximab - reopro
-
anti-platelet that acts on thrombocytopenia
acts at the bone site
decreases megkaryocyte
inhibits cAMP phoshpodiesterase IIIĀ
inhibits ADP and collagen induced platelet aggregation
anagrelide - agylin
-
anti-platelet used for intermittent claudication (periperal vascular disease)
contraindicated in CHF patients
phoshpodiesterase inhibitor
smoking decreases by 20%
cilostazol - pletal
-
a complication of PCTA where the acute vessel recoils and post-injury arterial shrikage (constrictive remodleing)
balloon angioplasty alone
-
a complication of PCTA with an increase risk of sub-acute thrombosis that can result from a non-drug coated stent
restenosis
-
the main cause of drug coated stents that resis stenosis
thrombotic occlusions because anti-platelet therapy is withdrawn to early
-
material that was the first coating on a stent
heparin
-
ST-segment elevation in leads V1,V2,V3,I,aVL
ishcemia
-
aVR and ST segment depression in leads V4,V5,V6,II,III and a VF
infarct
-
suicide substrate produced from metabolism of clopidogrel
sufeneic acid
-
any important point to remember about clopidogrel
inform dentists if you are on
-
avoid with the use of this with clopidogrel because of the CYP2C19 inhibition
omeprazole (PPI's)
-
what is exposed that causes platelet aggregation and restenosis
collagen
-
anti-platelet prodrug used for the prevention of stroke and sickle cell disease
used for those intolerant to ASA
blood dyscrasias
inhibits ADP-induced platelet fibrinogen (nonreversible)
ticlopidine - ticlid
-
what occurs physically to a coronary artery resulting in a myocardial infarction
- occlusion from a blood clot
- vasospasm
- plaque buildup
-
how do you resolve a blood clot in MI
thrombotic therapy
-
how do you remove plaque
PCTA - percutaneous transluminal angioplasty
-
complication where you puncture the blood vessel and mandate immediate coronary bypass surgery
david letterman experience
-
myocardial injury caused by the restoration of coronary blood flow AFTER an ischemic event
myocardial re-perfusion injury
-
CYP enzyme order of clopidogrel metabolism
2C19-->450/O2,NADPH
-
thrombotic therapy
TPN, streptokinase, urokinase (kidney)
-
no thrombus or occlusive plaque present "silent heart attack"
vasospasm
-
intervention of radiation to prevent restenosis
intravascular brachytherapy
-
alternative to intravascular brachytherapy
stent deployment
-
which stents are more likely to produce late stent thrombosis
DES > BMS
|
|